Translating Science from Bench to Bedside: A Case for Extracellular Vesicles

Thursday, February 29 | 9 a.m. ET | Online

Speaker: Dr. Carlos Salomon Gallo

Dr. Salomon is the head of the Translational Extracellular Vesicles in Obstetrics and Gynae-Oncology Group, NHMRC Investigator Fellow and is considered a worldwide authority on extracellular vesicles (EVs) biomarkers for complications of pregnancies and ovarian cancer (OC). In the last 10 years, Dr. Salomon’s primary research and commercialization activities have focused on the identification and validation of biomarkers, and development of In Vitro Multivariate Index Assays for clinically relevant complications (including ovarian cancers, and obstetrical syndromes) and their translation into clinical applications. He is a pioneer in investigating the release of EVs by the placenta and tumor cells and their utility as a biomarker for a wide range of pregnancy complications and OC.

This talk will cover the burgeoning field of EVs signaling holds the potential to revolutionize our understanding of cancer biology and offers new avenues for non-invasive diagnostics and therapeutic interventions. EVs have been implicated in various aspects of cancer progression, including tumor initiation, metastasis, and response to therapy. From the early stages of tumor development, tumor-derived EVs are detectable in the circulation.

To learn more and register, visit the GGMC Educational Webinar Series webpage.

Please note: Registration is required for this webinar.